A sulfonylurea drug that stimulates the pancreas to release more insulin.
A biguanide that improves insulin sensitivity and reduces glucose production by the liver.
A thiazolidinedione (tzd) that improves insulin sensitivity by acting on cells' insulin receptors.
Type 2 diabetes mellitus in adults where diet and exercise alone have not achieved adequate glycemic control.
Specifically used in patients who require a combination therapy to manage their blood sugar levels effectively.
This combination medication works synergistically. Glimepiride increases insulin secretion, Metformin enhances insulin sensitivity and reduces hepatic glucose production, and Rosiglitazone improves insulin sensitivity at the cellular level. This combined action helps to lower blood glucose levels.
Store at room temperature (20-25°C) away from moisture and direct sunlight. Keep out of reach of children. Discard any unused medication after its expiration date.
Dosage should be determined by a physician based on individual needs and response.
It is usually taken orally with meals.
The physician will carefully adjust the dose to find the most effective and safest regimen for each patient.
Never alter the dosage or discontinue the medication without consulting a doctor.
Weight gain (Rosiglitazone): Fluid retention is possible.
Liver problems (Rosiglitazone): Rare but potentially serious, requiring regular liver function monitoring.
Heart failure (Rosiglitazone): Increased risk, especially in patients with pre-existing heart conditions.
Lactic acidosis (Metformin): A rare but serious complication primarily in patients with kidney impairment.
Hypoglycemia (low blood sugar): Symptoms may include dizziness, sweating, shaking, confusion, and fainting.
Gastrointestinal issues (Metformin): Nausea, vomiting, diarrhea, and abdominal pain.
Allergic reactions: Rash, itching, swelling.
Alcohol can increase the risk of hypoglycemia and should be limited or avoided, especially with Glimepiride.
Hypoglycemia can impair judgment and coordination. Avoid driving or operating machinery if experiencing low blood sugar symptoms.
Use is generally not recommended during pregnancy or breastfeeding. Consult your doctor immediately.
Not indicated for use in children.
Caution is required in patients with kidney disease. Metformin may need to be adjusted or avoided altogether.
Regular monitoring of liver function is necessary, particularly when using Rosiglitazone.
Your physician's advice and the medicine's package insert are primary sources.
Reputable medical websites and journals should be consulted for further information. Always verify information with your healthcare provider.
